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Abstract
Introduction and hypothesis This study aims to examine
the relationship between pelvic floor muscle function
(PFMF) and pelvic organ prolapse (POP) in a general
female population.
Methods Cross-sectional study on women aged 45–
85 years. Validated questionnaires were used to assess
pelvic floor muscle function. POP and PFMF were
evaluated with vaginal examination. For statistical analysis
chi-squared test for trend and analysis of variance were
used.
Results Response rate to the questionnaire was 62.7%
(1,869/2,979). No significant differences were found in
muscle strength and endurance during voluntary muscle
contraction between the POP stages. Women with POP
stages I and II were significantly less able to achieve
effective involuntary muscle contraction during coughing
(38.3% and 37.7%) than women without POP (75.2%).
Conclusion Involuntary contraction of the PFM during
coughing (that resulted in stabilization of the perineum)
was significantly weaker in the women with POP stage I
and II than in the women without POP.
Keywords Pelvic floor musculature . Pelvic floor muscle
function . Pelvic organ prolapse . Involuntary contraction .
Intra-abdominal pressure
Introduction
Pelvic organ prolapse (POP) is a common condition that
affects around 75% of women of all ages and parity, but it
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is not always symptomatic [1]. By the age of 79 years,
women have an 11% chance of undergoing at least one
surgical treatment for incontinence or POP, with a 29.2%
risk of recurrent surgery [2]. The medical cost of POP is
high (more than one billion dollars a year in the USA) [3]
and is expected to increase due to global aging. We are
therefore faced with the challenge of obtaining knowledge
about its pathophysiology in order to achieve adequate
prevention or treatment [4].
POP has been attributed to a decrease in pelvic floor
muscle support that results in widening of the genital hiatus
and stretching of the connective tissue, which enables
downward movement of the pelvic organs [5].
Known risk factors for POP are parity, family history,
surgery for urinary incontinence (UI) or advanced stage
POP, overweight, menopause, race, medication, heavy
lifting, increased chronic abdominal pressure caused by
heavy physical work or lung disease and smoking, [1, 6].
Unfortunately, it is not easy to prevent exposure to most of
these risk factors.
Although surgery is the preferred treatment, the recurrence
versus no recurrence of POP after surgical repair reported in
one study was 34.6% [7]. It was associated with reduced
strength of the levator ani (35.8% versus 0%, p=0.017) and
a genital hiatus of 5 cm or larger (44.2% versus 27.8%).
Therefore, the question arises as to whether surgery is the
optimal and only option to treat POP. As its pathogenesis
starts with loss of support of the pelvic floor musculature
(PFM), training these muscles might be an effective
conservative treatment for POP. Support for muscle training
was found in a pilot randomized controlled trial by Hagen et
al. [8] in which the women with POP stages I and II showed
a decrease in POP symptoms and objective and subjective
improvement. The PFM training protocol not only included
strength and endurance, but women also were taught to
voluntary contract the PFM prior to activities such as
coughing in order to train the involuntary muscle response.
It is not clear whether this training protocol is the
optimal answer to conservative treatment. However, trials
are currently underway. Knowledge is still lacking on PFM
functioning (PFMF) in women with POP. Only one study
has been performed on the analysis of PFM activity in
women with POP prior to corrective surgery [9]. They
found a significant relation between weak PFM and severe
POP in a multicentre trial. However, they did not use the
standardized PFM terminology as put forward by the
International Continence Society (ICS) [10]. Especially
the assessment of the involuntary contractions of the PFM
was lacking.
In order to design an optimal training program for the
PFM in women with POP, knowledge is required on the
relation between PFMF (muscle strength, endurance
assessed by voluntary muscle contraction, and coordination
assessed by involuntary muscle contraction) and POP stage
in a general female population. Therefore, the aims of our
study were to determine:
1. the relation between POP and PFMF in women with
and without POP symptoms of vaginal bulging
2. the relation between POP stage and PFMF using the
traditional POPQ measurements and a recently devel-
oped ICS PFM assessment tool including both volun-
tary and involuntary PFM contractions[11]
Material and methods
A cross-sectional study was performed on a general
population of mostly white women, aged 45 to 85 years,
living in a Dutch town. Figure 1 presents the flowchart of
the study.
The total population of women in this age range (n=
2,979 out of 16,000 citizens), registered on the lists of eight
out of the nine general practices in the town of Brielle (near
Rotterdam, The Netherlands), were approached to partici-
pate in the present study. As all the inhabitants are obliged
to register with a general practitioner, the study population
included 95% of the women in this age range in the town.
Five percent of the female population was missing since
one practitioner did not participate. The women were sent
information about the study and they could enroll by filling
out an informed consent form. They were offered three
options: to sign a refusal form, to fill out the questionnaire
only, or to fill out the questionnaire and undergo vaginal
examination.
After receiving the informed consent the women who
agreed to participate were asked to complete a self-report
questionnaire. Non-responders received a reminder 8 weeks
later that contained the same questionnaire. The data were
collected anonymously. To encourage a high response to
the questionnaire, we used envelopes with the name and
logo of the Erasmus University, colored paper, and
stamped-addressed return envelopes [12]. Each reminder
included the same questionnaire. To investigate selection
bias, non-responders to the reminders were invited to
complete a short questionnaire that comprised five ques-
tions about: age, parity, presence of stress urinary inconti-
nence (yes/no), fecal incontinence (yes/no), and feeling of
vaginal bulging (yes/no).
The questionnaires used in this study combined several
validated Dutch versions of pelvic floor questionnaires,
such as the Urogenital Distress Inventory [13] and the
Defecation Distress Inventory [14]. Data extracted from the
questionnaires, presented in this article, included body mass
index (BMI), ethnicity, educational level, parity, menopaus-
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al status, hormone replacement therapy, smoking, previous
pelvic floor surgery, family history, and heavy physical
work undertaken currently or in the past. Women were
defined as postmenopausal when their last menstruation
had occurred at least 12 months previously. Women were
defined symptomatic for prolapse when they answered
positive on the question ‘do you see and/or feel a vaginal
bulge?’
Vaginal examination
From the group of participants who gave informed consent to
undergo vaginal examination (n=1,140, group 1B), 800
women were randomly selected for PFMF assessment and
POPQ measurement (group 2). (All the response forms were
coded with a number that identified the women’s age and
then a research assistant selected the study sample at random
by age). All the vaginal examinations were performed at the
women’s own general practice in the spring period of 2004.
The women were asked to empty their bladder before the
examination and were then placed on the examination table
in the lithotomy position, with a slightly elevated body and
the legs bent to about 30° of flexion.
Table 1 presents the PFMF assessment method, the
criteria, and verbal instructions. Voluntary muscle contrac-
tion (VMC) and effective involuntary muscle contraction
(IMC) during coughing, relaxation, and straining were
scored by visual inspection and digital palpation. Data were
also obtained using the reliable and valid POPQ measure-
ment method, developed by the ICS [15].
One gynecologist and one physiotherapist performed all
the vaginal examinations. Each participant was assessed
once. A great deal of attention was paid to training the two
examiners before starting the study. They practiced the
vaginal examination protocol until 100% agreement was
reached between their scores. This process was performed
Women aged 45-85 
years n=2,979 
Invited for study   
informed consent 
Responders  
n=1,869
Moved/died 
 n=59 
Non-responders after 
reminder   
n=1,051
Short questionnaire 
n=1,051
Non-responders 
n=431 
Responders n=620  
No agreement 
n=472 (25.2%) 
Agreed to quest. 
alone n=257 
(13.7%) 
= Group 1A 
= Group 3 
Agreed to quest. and 
vaginal exam. 
n=1140 
(60.9%) 
Random selection and 
invited for vaginal exam. 
n= 800
Non-responders to 
vaginal exam. 
invitation n=151 
Responders to 
vaginal exam. 
invitation n=649 
= Group 2 
= Group 1B 
Fig. 1 Flowchart of the study
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at the Pelvic Floor Centre of the Erasmus Medical Centre,
Rotterdam, The Netherlands. The two examiners were
blinded to the results of the questionnaire. The Medical
Ethics Research Committee (METC) of the Erasmus
Medical Centre approved this study.
Statistical analysis
Individual PFM items that consisted of yes/no scores or
three category scores were compared in relation with the
five POPQ stages and the symptom of vaginal bulging in
two categories, by means of chi-square tests and tests for
trends. Analysis of variance (ANOVA), testing for a
difference across response categories, was used to compare
the outcome on the PFM item endurance (scored as
continuous variable). The level of significance was set at
p<0.05. All the analyses were performed using the
Statistical Package for Social Science (SPSS Inc) 15.0.
Results
Response rate
The response rate to the questionnaire was 62.7% (1869/
2979). In the group of 1,869 responders, 472 (25.2%)
women refused to participate, 257 (13.7%) women (group
1A in Table 2) agreed to fill out the large questionnaire
only, and 1,140 (60.9%) agreed to fill out the questionnaire
and undergo vaginal examination (group 1B). Eight
hundred out of the 1,140 women were selected at random
and sent an invitation to undergo vaginal examination
Table 1 PFM assessment with outcome and outcome measures between parenthesis: verbal instruction
Outcome Outcome measures
Visual inspection
Co-contraction visible Yes Any co-activity of muscles other than TrAb
No No co-activity of other muscles visible
Incontinence during coughing Yes
No
Palpation during voluntary muscle contraction Abbreviation: VMC
(‘Lift and squeeze your PFM’ and if this was not helpful enough, ‘try to avoid loss of urine or flatus’)
Urethral lift Yes Any urethral lift palpable
No No urethral lift is palpable
Inward movement perineum Yes Any inward movement of the perineum
No No inward movement of the perineum
Downward Any downward movement of the perineum
Levator closure Yes Any levator closure movement palpable
No No levator closure movement palpable
Voluntary relaxation Complete Direct beyond rest level
Partly Direct relaxation to rest level
Absent No relaxation palpable
Maximal voluntary contraction (‘lift and squeeze your PFM as
hard as possible’)
Strong Strong closure and lifting cranio-anterior movement palpable
Normal Closure and lifting cranio-anterior movement palpable
Weak Short contraction, no closure palpable
Absent No contraction
Endurance 1 to 10
(‘Make a steady but firm contraction and hold it as long as you can, while repeating hold and hold and hold’)
Palpation during involuntary muscle contraction during
coughing (‘cough forcefully’)
Abbreviation: IMC
Movement perineum Yes No or ineffective contraction that allows any downward
movement of the perineum
No Effective IMC that results in no downward movement of the
perineum
During straining (‘give a strong push’) involuntary relaxation Yes Any downward movement of the perineum
No No downward movement
VMC voluntary muscle contraction, IMC involuntary muscle contraction
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(group 2): 653 women complied (81.6%). Thus, a total of
46.7% women who participated in the study underwent the
vaginal examination (649/1,397). In the non-responder
group who did not respond to the first and second requests
to participate in the study (group 3), 59% completed and
returned the short questionnaire (620/1,051).
Demographic characteristics
Demographic characteristics of the total study population
and the different groups (group 1(A+B) and the vaginal
examination group 2) are presented in Table 2. No
significant differences in demographic characteristics were
found between group 1 (total questionnaire group) and
group 3 (the non-responder group who replied to the short
questionnaire). In the vaginal examination group, 79 out of
the 649 women reported seeing and/or feeling vaginal
bulging (scored by the questionnaire). No significant
differences were found in the demographic characteristics
between these three groups.
PFMF and the POP symptom of vaginal bulging
Table 3 presents the different components of PFMF
potentially associated with symptomatic and asymptomatic
POP in women who had a vaginal examination. There were
no significant differences in any of the PFMF items
between women with and women without POP symptoms,
except for voluntary relaxation of the PFM that had a
significant score (p=0.011). More women who were
symptomatic for vaginal bulging had better voluntary
relaxation compared to the asymptomatic women (64.4%
versus 49.7%)
PFMF versus POPQ
Table 4 presents the POPQ stage versus the different PFMF
items. All the components of PFMF in the women with
stage I–IV POP were compared to those in the women
without POP and tested for significance. Prevalence of
POPQ stage were 25% (161) for stage 0, 36.5% (235) for
stage I, 33% (212) for stage II, 5% (32) for stage III, and
0.5% (3) for stage IV (from six women POPQ data were
missing). Visible co-contractions (less often visible in stage
0 than in higher stages), incontinence during coughing
(increasing prevalence with increasing stage), and levator
closure (decreasing prevalence with increasing stage)
differed significantly between the groups (resp. p=0.006,
p=0.001, and p=0.001). POP stage had a significant
influence on effective involuntary PFM contraction (IMC)
to counteract a sudden increase in intra-abdominal pressure
(IAP) during coughing (75.2% in stage 0 versus 38.3% in
stage I and 37.7% in stage II, p=0.001). Significant
differences were also found in the caudal movement of
the perineum during straining. Women with the lower
stages of POP were less able to perform the proper straining
technique than the women with ≥stage II.
Table 2 Demographic characteristics of the total study population
and those who underwent vaginal examination expressed as numbers
(%) and means
Characteristics of the
total study population
Questionnaire
(total groups
1A and 1B)
Vaginal exam.
(total group 2)
n=1,397c n=649
Mean age
(range 45–84 years)
58.0 (SD±9.2) 58.3 (SD±9.0)
Mean BMI n=1,364 n=634
25.6 (SD±3.9) 25.6 (SD±3.7)
Race n=1,372 n=640
White 1,351 (96.7) 632 (97.4)
Non-white 20 (1.4) 8 (1.2)
n=1340 n=639
Median parity 2 2
0 120 (8.6) 49 (7.6)
1 215 (15.4) 86 (13.3)
2 675 (48.3) 321 (49.5)
≥3 387 (27.7) 183 (28.2)
Educational level n=1,374 n=634
Primary only 139 (9.9) 70 (11.1)
Intermediate 1,039 (75.6) 480 (75.7)
Higher 196 (14.3) 84 (13.2)
Menopausal status n=1,383 n=645
Premenopausal 374 (26.8) 167 (25.7)
Postmenopausala 1,009 (72.2) 478 (73.7)
Smoking n=1,382 n=642
Current smoker 280 (20) 134 (20.6)
Surgical history n=1,384 n=645
Prolapse 103 (7.4) 54 (8.3)
n=1,382 n=643
Incontinence 47 (3.4) 24 (3.7)
n=1,383 n=643
Hysterectomy 234 (16.8) 109 (16.8)
Family history n=985 n=441
Mother POP 359 (25.7) 161 (36.5)
n=870 n=398
Mother UI 258 (29.7) 122 (30.6)
Heavy physical workb n=1,381 n=642
Currently 269 (19.3) 130 (20)
n=1,384 n=645
Ever 619 (44.3) 293 (45.1)
aWomen whose last menstruation occurred at least 1 year previously
b Heavy physical work: long-term, much lifting and bending
c Due to missing data percentages do not always correspond with the
total group
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Discussion
This was the first study that tested PFMF in relation to POP
in a general female population. We found a significant
difference in effective IMC to counteract sudden increases
in IAP during coughing between the women without POP
and those with different stages of POP. It is difficult to
explain why there was such an enormous decrease in the
ability to resist IAP in the women with stage I POP. Future
research should address whether this decrease is a contrib-
uting factor to the development of POP.
The item PFMF levator closure during VMC demon-
strated significant differences between the POP stages. We
hypothesize that part of the process of POP development
next to the demonstrated widening of the genital hiatus [16]
can be a weak ability to perform levator closure during an
increase in IAP. It is a well-recognized physiological
process that during physical activities, people hold their
breath and stabilize their diaphragm to create greater
strength and consequently, a strong increase in IAP. PFM
are reflex activated during any stress. This activation is
preset in particular motor patterns such as coughing and is
not just a reflex response to increased IAP [17]. Such
increases in IAP are present not only during heavy lifting or
sports, but also in daily activities and they require optimal
IMC. Our study revealed that muscle strength and endur-
ance were not significantly different between the POP
stages. Although strength and endurance are necessary to
have optimal levator closure, our findings support the
assumption that muscle strength and endurance are not the
only key issues in the design of new treatment strategies or
preventive measures for POP. No significant differences in
PFMF were found between the women who reported that
they were symptomatic for vaginal bulging and those
without these symptoms, except for relaxation after VMC.
In one of our earlier publications, vaginal examination
Table 3 Pelvic floor muscle function in numbers (percentages) in women who were symptomatic or asymptomatic for POP symptoms
Response Symptomatic for POP (n=79) Asymptomatic for POP (n=570) p valuea
Visual inspection
Co-contraction visible Yes 26 (33.8) 194 (34.8) 0.486
No 51 (66.2) 364 (65.2)
Incontinence during coughing Yes 9 (11.4) 47 (8.4) 0.244
No 70 (88.6) 513 (91.6)
Palpation during voluntary muscle contraction
Urethral lift Yes 45 (60) 342 (63) 0.352
No 201 (37) 201 (37)
Inward movement perineum Yes 63 (81.8) 420 (76.2) 0.230
No 14 (18.2) 126 (22.9)
Downward 0 5 (0.9)
Levator closure Yes 45 (59.2) 337 (62.3) 0.345
No 31 (40.8) 204 (37.7)
Voluntary relaxation Good 47 (64.4) 259 (49.7)
Delayed 18 (24.7) 152 (29.2) 0.011
Incomplete 8 (11) 110 (21.1)
Voluntary contraction Absent 4 (5.1) 29 (5.2) 0.592
Weak 26 (32.9) 175 (31.3)
Normal 47 (59.5) 326 (58.2)
Strong 2 (2.5) 30 (5.4)
Mean (SD) Mean (SD)
Endurance 0–10 s 6.25 (3.11) 6.25 (3.31) 0.987
Palpation during involuntary muscle contraction while coughing
Downward movement perineum Yes (ineff. IMC) 41 (51.9) 291 (52) 0.543
No downward movement perineum No (eff. IMC) 38 (48.1) 269 (48)
Palpation during involuntary muscle relaxation while straining
Caudal perineal movement during straining Yes 73 (93.6) 493 (89.5) 0.177
No caudal movement No 5 (6.4) 58 (10.5)
a Statistical comparison by chi-squared test for trend, except for mean endurance in seconds: F test from ANOVA
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revealed that only 30.7% of the women with POP ‘at or
beyond the hymen’ were symptomatic [18]. This might
explain the lack of significant differences in PFMF between
the symptomatic group and the asymptomatic group.
Several recommendations can be made for POP treat-
ment and preventive measures based on our study results.
Apparently, strong PFM alone does not seem to prevent the
development of POP; however, we must be careful making
these conclusions due to the character of this study. To
study the effect of PFM training on the prevention and
treatment of POP, Bo [19] reviewed basic research and
case–control studies and put forward two hypotheses: (1)
women can learn to contract their PFM consciously before
and during an increase in IAP and will continue to make
such contractions as a behavioral modification in order to
prevent descent of the pelvic contents and (2) women can
learn to build up ‘muscle tone’ and structural support of the
pelvic floor through regular strength training over time.
Owing to the lack of high-quality randomized controlled
trials on the effect of PFM training in women with POP,
Table 4 Association between pelvic floor muscle function and pelvic organ prolapse, measured with the POPQ
Outcome PFMF versus vaginal examination
Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 p valuea
n=161 n=235 n=212 n=32 n=3
Visual inspection
Co-contraction visible Yes 41 (25.8) 83 (35.5) 85 (40.3) 10 (31.3) 3 (100) 0.006
No 118 (74.2) 151 (64.5) 126 (59.7) 22 (68.8) 0
Incontinence during
coughing
Yes 2 (1.2) 22 (9.4) 29 (13.7) 2 (6.3) 3 (100) 0.001
No 159 (98.8) 213 (90.6) 183 (86.3) 93.8 (30) 0
Palpation during voluntary muscle contraction
Urethral lift Yes 109 (69) 145 (63.6) 116 (56.9) 17 (58.6) 1 (33.3) 0.137
No 49 (31) 83 (36.4) 88 (43.1) 12 (41.4) 2 (66.7)
Inward movement perineum Yes 122 (76.7) 182 (78.4) 153 (74.6) 24 (77.4) 2 (66.7) 0.495
No 37 (23.3) 48 (20.7) 49 (23.9) 7 (22.6) 1 (33.3)
Downward 0 2 (0.9) 3 (1.5) 0 0
Levator closure Yes 122 (77.2) 147 (65) 100 (49) 16 (53.3) 0 0.001
No 36 (22.8) 79 (35) 104 (51) 14 (46.7) 3 (100)
n=150 n=219 n=195 n=31 n=3
Voluntary relaxation Good 67 (44.7) 116 (53) 101 (51.8) 20 (64.5) 2 (66.7) 0.088
Delayed 52 (34.7) 51 (23.3) 62 (31.8) 4 (12.9) 1 (33.3)
Incomplete 31 (20.7) 52 (23.7) 32 (16.4) 7 (22.6) 0
n=161 n=235 n=211 n=32 n=3
Maximum voluntary
contraction
Absent 8 (5) 14 (6.0) 12 (5.7) 0 0 0.280
Weak 53 (32.9) 61 (26) 75 (35.5) 12 (37.5) 2 (66.7)
Normal 91 (56.5) 145 (61.7) 117 (55.5) 20 (62.5) 1 (33.3)
Strong 9 (5.6) 15 (6.4) 7 (3.3) 0 0
n=161 n=234 n=212 n=32 n=3
Mean endurance in seconds 0–10 s 6.51
(SD 3.2)
6.35
(SD 3.39)
5.93
(SD 3.25)
6.28
(SD 3.15)
4.00
(SD 1.00)
0.332
Palpation during involuntary muscle contraction while coughing
Downward movement
perineum
No, meaning effective IMC 121 (75.2) 90 (38.3) 80 (37.7) 20 (62.5) 0 0.001
Downward movement
perineum
Yes, meaning
Ineffective IMC 40 (24.8) 145 (61.7) 132 (62.3) 12 (37.5) 3 (100)
Palpation during involuntary muscle relaxation while straining
Caudal perineal movement
during straining
Yes 127 (80.4) 210 (90.5) 199 (95.7) 30 (93.8) 3 (100) .001
No caudal movement No 31 (19.6) 22 (9.5) 9 (4.3) 2 (6.3) 0
Numbers (percentages)
a Statistical comparison by chi-squared test for trend, except for mean endurance in seconds: F test from ANOVA
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neither of the hypotheses could be confirmed. Longitudinal
studies are necessary to provide reliable evidence. Some
women might achieve greater PFM strength and endurance
as a direct reaction to the development of POP, whereas
others might experience deterioration in PFMF due to the
progression of POP. It seems that good coordination of the
PFM, as demonstrated by effective IMC, is more important.
Normal or strong VMC and good PFM endurance do not
guarantee effective IMC of the PFM [20]. Therefore,
clinicians should test VMC and IMC to gain insight into a
woman’s ability to counteract any sudden increase in IAP.
Based on the results of the present study, the inclusion of
effective IMC of the PFM in new treatment plans gives an
indication of a likely effectiveness, as was shown in the
recent pilot RCT study by Hagen [8], in which women with
stages I and II POP were treated effectively with a protocol
that included greater awareness of the location of the PFM
and the importance of pre-contraction before an IAP
increase, for example when coughing or lifting. In daily
practice, it will be challenging to recruit the women without
POP and women with stage I so that PFM awareness and
training can be started at an early stage in the form of
preventive measures. In a recent study, a new combination
of risk factors was identified, namely vaginal bulging
during pregnancy, a family history of POP, and heavy
physical work [6]. The first steps are the organization of
antepartum or postpartum training groups and ‘POP-
prevention-groups’ for women at risk.
Some reservation must be taken into account when
making assumptions about the effect of PFM training to
prevent the development or progression of POP. Postpartum
MRI and ultrasound studies have demonstrated asymmet-
rical damage, avulsions, and abnormalities of the pelvic
floor [21, 22]. As the pelvic floor is primarily seen as a
functional unit (that combines the closure system of the
excretory tracts, support system for the pelvic viscera, and a
participating unit in the sexual response) it does not seem to
be possible to activate the right half or left half of the PFM
separately, or to strictly separate activation of individual
pairs of muscles [17, 23]. Therefore, it would be worth-
while to study the effect of PFM training in women with
asymmetrical damage, in relation to the prevention of POP
or other symptoms of pelvic floor dysfunction.
Strengths and limitations
The strength of our study was the ethnic homogeneity,
because almost all of the women were white, which
eliminated racial bias from the results. Furthermore, broad
data were obtained from a large general study group using a
combination of questionnaires and vaginal examination.
However, despite the high compliance, selection bias can
never be excluded. Another limitation was the lack of
blinding of the assessors for the POPQ results. This might
cause some bias. However, we regard this possible bias not
as a major problem since (a) no interpretation of the results
was made during the assessment and (b) the findings of this
study were not hypothesized prior to the study.
Another remark can be made regarding the assessment
scheme used. Although face validity and reliability of the
assessment scheme was tested prior to this study only one study
supports the use of this assessment of pelvic floor muscle
function. We would recommend further research to demon-
strate the value of this assessment scheme in larger populations.
This study was performed on a general population of
mainly white women (98%) with a mean BMI of 25.
Therefore, extrapolation to other populations has to be
performed with caution.
Conclusions
Women with POP lacked effective IMC of the PFM. More
knowledge is needed on the role of PFM training in
prevention of POP and the pathogenesis of POP.
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